ATR three-lens brief
Evidence-based stock research on ATR. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Outperforming SPY by 18.5pp over 30 days.
- Outperforming SPY by 18.5pp over 30 days.
- Reported earnings on 2026-10-29.
- Ex-dividend date 2026-11-12.
ATR closed at $143.08 (-0.72%) as of 2026-11-12. Market cap: $9.07B. P/E (trailing) 34.6. Price is above the 50-day MA and above the 200-day MA. Positives: outperforming SPY by 18.5pp over 30 days.. Last quarter: Revenue $1.02B, net income $32.60M, free cash flow $255.67M.
Why three lenses on ATR, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ATR across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/ATR" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ATR brief"></iframe>